SHEA GERSTENMAIER: Open Payments
NPI 1790464501 · DANBURY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 7 payments from 5 companies in 2025. Trend: 2023 $622 · 2024 $171 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $116 |
| Intra-Sana Laboratories | 1 | $50 |
| GlaxoSmithKline, LLC. | 2 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Insmed, Inc. | 1 | $20 |
Products named: AIRSUPRA, RELTONE 200 MG, BREZTRI, NUCALA, TRELEGY ELLIPTA, GLASSIA, Arikayce.
Industry payments across CT — which companies pay providers there.
